Your browser doesn't support javascript.
loading
Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome.
Moore, Jeremy P; Gallotti, Roberto G; Shannon, Kevin M; Bos, J Martijn; Sadeghi, Elham; Strasburger, Janette F; Wakai, Ronald T; Horigome, Hitoshi; Clur, Sally-Ann; Hill, Allison C; Shah, Maully J; Behere, Shashank; Sarquella-Brugada, Georgia; Czosek, Richard; Etheridge, Susan P; Fischbach, Peter; Kannankeril, Prince J; Motonaga, Kara; Landstrom, Andrew P; Williams, Matthew; Patel, Akash; Dagradi, Federica; Tan, Reina B; Stephenson, Elizabeth; Krishna, Mani Ram; Miyake, Christina Y; Lee, Michelle E; Sanatani, Shubhayan; Balaji, Seshadri; Young, Ming-Lon; Siddiqui, Saad; Schwartz, Peter J; Shivkumar, Kalyanam; Ackerman, Michael J.
Afiliação
  • Moore JP; Division of Pediatric Cardiology, University of California Los Angeles (UCLA) Medical Center, Los Angeles, California, USA; UCLA Cardiac Arrhythmia Center and Ahmanson Adult Congenital Heart Disease Center, UCLA Health System, Los Angeles, California, USA. Electronic address: jpmoore@mednet.ucla.edu
  • Gallotti RG; Division of Pediatric Cardiology, University of California Los Angeles (UCLA) Medical Center, Los Angeles, California, USA; UCLA Cardiac Arrhythmia Center and Ahmanson Adult Congenital Heart Disease Center, UCLA Health System, Los Angeles, California, USA.
  • Shannon KM; Division of Pediatric Cardiology, University of California Los Angeles (UCLA) Medical Center, Los Angeles, California, USA; UCLA Cardiac Arrhythmia Center and Ahmanson Adult Congenital Heart Disease Center, UCLA Health System, Los Angeles, California, USA.
  • Bos JM; Department of Cardiovascular Medicine (Division of Heart Rhythm Services), Mayo Clinic, Rochester, Minnesota, USA; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Molecular Pharmacology and Experimental Therapeu
  • Sadeghi E; Department of Pediatrics, Medical College of Wisconsin, Herma Heart Institute, Milwaukee, Wisconsin, USA.
  • Strasburger JF; Department of Pediatrics, Medical College of Wisconsin, Herma Heart Institute, Milwaukee, Wisconsin, USA.
  • Wakai RT; Biomagnetism Laboratory, Department of Medical Physics, University of Wisconsin, Madison, Wisconsin, USA.
  • Horigome H; Department of Pediatrics, Tsukuba University, Ibaraki, Japan.
  • Clur SA; Department of Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Hill AC; Division of Cardiology, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Shah MJ; Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Behere S; Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Sarquella-Brugada G; Arrhythmia, Inherited Cardiac Diseases Unit, Hospital Sant Joan de Déu, Barcelona, Spain; Medical Sciences Department, School of Medicine, University of Girona, Girona, Spain.
  • Czosek R; The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Etheridge SP; Primary Children's Hospital, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Fischbach P; Division of Pediatric Cardiology, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA.
  • Kannankeril PJ; Monroe Carrell Children's Hospital, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Motonaga K; Division of Pediatric Cardiology, Stanford University, Palo Alto, California, USA.
  • Landstrom AP; Department of Pediatrics, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Williams M; Division of Cardiology, Rady Children's Hospital, University of California San Diego, San Diego, California, USA.
  • Patel A; Division of Pediatric Cardiology, University of California San Francisco Benioff Children's Hospital, University of California, San Francisco, California, USA.
  • Dagradi F; Center for Cardiac Arrhythmias of Genetic Origin, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Auxologico Italiano, Milan, Italy.
  • Tan RB; Division of Pediatric Cardiology, New York University Langone School of Medicine, New York, New York, USA.
  • Stephenson E; Labbatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Krishna MR; Amrita Institute of Medical Science, Kochi, India.
  • Miyake CY; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA.
  • Lee ME; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA.
  • Sanatani S; Division of Cardiology, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Balaji S; Division of Pediatric Cardiology, Oregon Health and Science University, Portland, Oregon, USA.
  • Young ML; Joe DiMaggio Children's Hospital Heart Institute, Memorial Healthcare System, Hollywood, Florida, USA.
  • Siddiqui S; The Heart Institute for Children, Advocate Children's Hospital, Oak Lawn, Illinois, USA.
  • Schwartz PJ; Center for Cardiac Arrhythmias of Genetic Origin, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Auxologico Italiano, Milan, Italy; Department of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Molecular Cardiology Laboratory, Fondazione IRCCS Policlinico S. Matteo,
  • Shivkumar K; Division of Pediatric Cardiology, University of California Los Angeles (UCLA) Medical Center, Los Angeles, California, USA; UCLA Cardiac Arrhythmia Center and Ahmanson Adult Congenital Heart Disease Center, UCLA Health System, Los Angeles, California, USA.
  • Ackerman MJ; Department of Cardiovascular Medicine (Division of Heart Rhythm Services), Mayo Clinic, Rochester, Minnesota, USA; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Molecular Pharmacology and Experimental Therapeu
JACC Clin Electrophysiol ; 6(12): 1561-1570, 2020 11.
Article em En | MEDLINE | ID: mdl-33213816
ABSTRACT

OBJECTIVES:

This study sought to determine the relationship between long QT syndrome (LQTS) subtype (LTQ1, LTQ2, LTQ3) and postnatal cardiac events (CEs).

BACKGROUND:

LQTS presenting with 21 atrioventricular block or torsades de pointes in the fetus and/or neonate has been associated with risk for major CEs, but overall outcomes and predictors remain unknown.

METHODS:

A retrospective study involving 25 international centers evaluated the course of fetuses/newborns diagnosed with congenital LQTS and either 21 atrioventricular block or torsades de pointes. The primary outcomes were age at first CE after dismissal from the newborn hospitalization and death and/or cardiac transplantation during follow-up. CE was defined as aborted cardiac arrest, appropriate shock from implantable cardioverter-defibrillator, or sudden cardiac death.

RESULTS:

A total of 84 fetuses and/or neonates were identified with LQTS (12 as LQT1, 35 as LQT2, 37 as LQT3). Median gestational age at delivery was 37 weeks (interquartile range 35 to 39 weeks) and age at hospital discharge was 3 weeks (interquartile range 2 to 5 weeks). Fetal demise occurred in 2 and pre-discharge death in 1. Over a median of 5.2 years, there were 1 LQT1, 3 LQT2, and 23 LQT3 CEs (13 aborted cardiac arrests, 5 sudden cardiac deaths, and 9 appropriate shocks). One patient with LQT1 and 11 patients with LQT3 died or received cardiac transplant during follow-up. The only multivariate predictor of post-discharge CEs was LQT3 status (LQT3 vs. LQT2 hazard ratio 8.4; 95% confidence interval 2.6 to 38.9; p < 0.001), and LQT3, relative to LQT2, genotype predicted death and/or cardiac transplant (p < 0.001).

CONCLUSIONS:

In this large multicenter study, fetuses and/or neonates with LQT3 but not those with LQT1 or LQT2 presenting with severe arrhythmias were at high risk of not only frequent, but lethal CEs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do QT Longo / Assistência ao Convalescente Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do QT Longo / Assistência ao Convalescente Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2020 Tipo de documento: Article